<DOC>
	<DOCNO>NCT00659620</DOCNO>
	<brief_summary>Mesenchymal Stem Cell ( MSC ) show immunosuppressive repairing property . investigator infuse expand MSC patient develop Chronic Allograft Nephropathy . The purpose study find MSC effective preventing organ rejection maintain kidney function .</brief_summary>
	<brief_title>Mesenchymal Stem Cell Transplantation Treatment Chronic Allograft Nephropathy</brief_title>
	<detailed_description>Kidney transplantation common procedure hospital , organ rejection chronic nephrotoxicity potential problem patient . Approximately ninety percent protocol biopsy renal allograft , perform 18 month post transplantation , show histological lesion chronic calcineurin nephrotoxicity . Mesenchymal Stem Cell ( MSC ) show immunosuppressive repairing property . Some patient study also receive two infusion expand MSC . This study evaluate safety effectiveness MSC infusion patient . This study last 2 year . Participants randomly assign receive either full immunosuppressive therapy MSC infusion ( Group 1 ) immunosuppressive therapy alone ( Group 2 ) . Patients undergo MSC infusion start study Day 0 . One year post- infusion , patient evaluate . At Months 12 participant undergo kidney biopsy . Blood collection occur regular interval , Serum creatinine estimate creatinine clearance monthly record . The transplanted kidney function evaluate .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Recipients renal allograft , Male female patient age 18 60 year age . Ability provide write informed consent . The serum creatinine form 176umol/L ( 2mg/ml ) 440umol/L ( 5mg/ml ) Renal biopsy Criteria : chronic allograft nephropathy ( Banff III ) . Immunosuppressant : CNI MMF Sirolimus Written inform consent , compliant local regulation . Recipients leucopenia ( WBC &lt; 3000/mm³ ) , thrombocytopenia ( Thr &lt; 100.000/mm³ ) , hyperlipidemia ( Tot Chol &gt; 300 mg/dl Triglycerides &gt; 300 mg/dl ) . Recipients multiple organ . Pregnant woman . Previous history malignancy Active infection include hepatitis B , hepatitis C , HIV , TB determine positive skin test clinical presentation , treatment suspect TB . Evidence cardiovascular disease , exist congestive cardiac failure physical exam and/or acute coronary syndrome past 6 month . Inadequate compliance treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Kidney Transplant</keyword>
	<keyword>Chronic Allograft Nephropathy</keyword>
	<keyword>Mesenchymal Stem Cell infusion</keyword>
</DOC>